BlackRock’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $77.6M | Sell |
6,808,698
-1,177,195
| -15% | -$13.4M | ﹤0.01% | 2187 |
|
|
2025
Q1 | $94.9M | Buy |
7,985,893
+310,221
| +4% | +$3.69M | ﹤0.01% | 2001 |
|
|
2024
Q4 | $145M | Buy |
7,675,672
+494,137
| +7% | +$9.31M | ﹤0.01% | 1843 |
|
|
2024
Q3 | $161M | Buy |
7,181,535
+361,520
| +5% | +$8.12M | ﹤0.01% | 1770 |
|
|
2024
Q2 | $142M | Buy |
6,820,015
+2,239,601
| +49% | +$46.7M | ﹤0.01% | 1815 |
|
|
2024
Q1 | $67.3M | Sell |
4,580,414
-63,322
| -1% | -$931K | ﹤0.01% | 2246 |
|
|
2023
Q4 | $47.9M | Buy |
4,643,736
+125,182
| +3% | +$1.29M | ﹤0.01% | 2455 |
|
|
2023
Q3 | $35.5M | Sell |
4,518,554
-823
| -0% | -$6.47K | ﹤0.01% | 2572 |
|
|
2023
Q2 | $45.1M | Buy |
4,519,377
+228,237
| +5% | +$2.28M | ﹤0.01% | 2496 |
|
|
2023
Q1 | $38.1M | Buy |
4,291,140
+148,612
| +4% | +$1.32M | ﹤0.01% | 2589 |
|
|
2022
Q4 | $45.5M | Buy |
4,142,528
+419,438
| +11% | +$4.61M | ﹤0.01% | 2506 |
|
|
2022
Q3 | $48.5M | Buy |
3,723,090
+367,743
| +11% | +$4.79M | ﹤0.01% | 2430 |
|
|
2022
Q2 | $42.5M | Buy |
3,355,347
+830,704
| +33% | +$10.5M | ﹤0.01% | 2566 |
|
|
2022
Q1 | $35.4M | Sell |
2,524,643
-23,218
| -0.9% | -$325K | ﹤0.01% | 2742 |
|
|
2021
Q4 | $73.8M | Buy |
2,547,861
+64,288
| +3% | +$1.86M | ﹤0.01% | 2379 |
|
|
2021
Q3 | $74.4M | Buy |
2,483,573
+396,957
| +19% | +$11.9M | ﹤0.01% | 2372 |
|
|
2021
Q2 | $55.4M | Buy |
2,086,616
+269,927
| +15% | +$7.16M | ﹤0.01% | 2594 |
|
|
2021
Q1 | $56.5M | Buy |
1,816,689
+646,715
| +55% | +$20.1M | ﹤0.01% | 2504 |
|
|
2020
Q4 | $38.5M | Buy |
1,169,974
+500,176
| +75% | +$16.4M | ﹤0.01% | 2579 |
|
|
2020
Q3 | $23.4M | Buy |
+669,798
| New | +$23.4M | ﹤0.01% | 2707 |
|